Literature DB >> 36254326

Proposal for an Ambulatory Heart Failure Management Curriculum for Cardiology Residency Training Programs.

Aws Almufleh1, Ricky D Turgeon2,3, Anique Ducharme4, Filio Billia5, Justin Ezekowitz6.   

Abstract

Background: The suboptimal implementation of guideline-directed medical therapy (GDMT) for heart failure (HF) patients has been linked with poor clinical outcomes. Little is known about the potential role of cardiology residency training programs in improving trainees' (ie, future cardiologists') ability to utilize GDMT.
Methods: In this survey-based study, we examined the degree of exposure to ambulatory HF patient management among cardiology trainees in Canada. All cardiology residency program directors (n = 15; 100% response rate) completed our survey.
Results: Although 9 programs (60%) mandated ≥ 3 ambulatory cardiology rotations, only 3 (20%) required ≥ 2 ambulatory HF rotations. When HF rotations were provided, only 7 programs (47%) offered moderate or higher exposure to ambulatory nontransplant HF patients (defined as ≥ 5 clinics/rotations). This element was independent of program- and institution-specific characteristics. All institutions had a multidisciplinary HF clinic, and the majority (13 [87%]) had access to an inpatient HF service, a consultative HF service, and/or a specialist pharmacist. Furthermore, 13 program directors (87%) agreed on the importance of adopting HF training curriculum and their program's readiness to implement such a module. Conclusions: The current state of HF training among cardiology residencies is suboptimal and in need of improvement. Most programs have access to a HF clinic, a specialist pharmacist, or an inpatient consultative service, which would facilitate adoption of a HF management curriculum that focuses on practical and experiential aspects of GDMT optimization. This program, which is under development, will be offered to training programs nationwide, to enable trainees to manage this growing and increasingly complex patient population.
© 2022 The Authors.

Entities:  

Year:  2022        PMID: 36254326      PMCID: PMC9568682          DOI: 10.1016/j.cjco.2022.07.005

Source DB:  PubMed          Journal:  CJC Open        ISSN: 2589-790X


  5 in total

1.  ACC/AHA Special Report: Clinical Practice Guideline Implementation Strategies: A Summary of Systematic Reviews by the NHLBI Implementation Science Work Group: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Wiley V Chan; Thomas A Pearson; Glen C Bennett; William C Cushman; Thomas A Gaziano; Paul N Gorman; Joel Handler; Harlan M Krumholz; Robert F Kushner; Thomas D MacKenzie; Ralph L Sacco; Sidney C Smith; Victor J Stevens; Barbara L Wells
Journal:  J Am Coll Cardiol       Date:  2017-01-26       Impact factor: 24.094

2.  Target Doses of Heart Failure Medical Therapy and Blood Pressure: Insights From the CHAMP-HF Registry.

Authors:  Poghni A Peri-Okonny; Xiaojuan Mi; Yevgeniy Khariton; Krishna K Patel; Laine Thomas; Gregg C Fonarow; Puza P Sharma; Carol I Duffy; Nancy M Albert; Javed Butler; Adrian F Hernandez; Kevin McCague; Fredonia B Williams; Adam D DeVore; J Herbert Patterson; John A Spertus
Journal:  JACC Heart Fail       Date:  2019-02-06       Impact factor: 12.035

3.  Improving Practice Guideline Adherence Through Peer Feedback: Impact of an Ambulatory Cardiology Curriculum.

Authors:  Karl M Richardson; Jai Singh; Dan Muñoz; Julie B Damp; Lisa A Mendes
Journal:  Teach Learn Med       Date:  2018-01-24       Impact factor: 2.414

4.  Physician Perspectives on the Diagnosis and Management of Heart Failure With Preserved Ejection Fraction.

Authors:  Milan Gupta; Alan Bell; Michelle Padarath; Daniel Ngui; Justin Ezekowitz
Journal:  CJC Open       Date:  2020-11-16

Review 5.  Clinical inertia in the treatment of heart failure: a major issue to tackle.

Authors:  Caroline Verhestraeten; Ward A Heggermont; Michael Maris
Journal:  Heart Fail Rev       Date:  2021-11       Impact factor: 4.214

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.